| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $2K | — |
| R&D Expense | $3.3M | +1.4% |
| SG&A Expense | $4.5M | +23.6% |
| Operating Income | -$8.5M | -7.3% |
| Net Income | -$9.6M | -7.5% |
| EPS (Basic) | -$0.09 | +0.0% |
| EPS (Diluted) | -$0.09 | +0.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $159K | -94.7% |
| Current Assets | $233K | -92.4% |
| Total Assets | $492K | -85.3% |
| Current Liabilities | $48.4M | +17.7% |
| Stockholders' Equity | -$47.9M | -26.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.1M | +11.8% |
| Investing Cash Flow | -$12K | -1007.2% |
| Financing Cash Flow | $3.3M | -11.2% |